ArticleLeukemia2006

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia.

J Jin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.